{"id":54520,"date":"2023-03-06T15:04:35","date_gmt":"2023-03-06T14:04:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/"},"modified":"2023-03-06T15:04:35","modified_gmt":"2023-03-06T14:04:35","slug":"revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/","title":{"rendered":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–#biotechnews<\/a>–Revelation Biosciences Inc. (NASDAQ: REVB) (the \u201cCompany\u201d or \u201cRevelation\u201d), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March 12-14, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.\n<\/p>\n

<\/a><\/p>\n

\nDetails regarding Revelation fireside chat are as follows:\n<\/p>\n

\n35th Annual Roth Conference Presentation Details<\/b>\n<\/p>\n\n\n\n\n\n
\n

\nDate:\n<\/p>\n<\/td>\n

Tuesday, March 14, 2023<\/td>\n<\/tr>\n
\n

\nTime:\n<\/p>\n<\/td>\n

12:30 p.m. Pacific Time<\/td>\n<\/tr>\n
\n

\nLocation:\n<\/p>\n<\/td>\n

Healthcare – Salon 5 @ The Ritz Carlton, Laguna Niguel<\/td>\n<\/tr>\n
\n

\nWebcast:\n<\/p>\n<\/td>\n

REVB Webcast Link<\/a><\/td>\n<\/tr>\n<\/table>\n

\nA live webcast of the presentation will also be available in the Investor Relations section of Revelation\u2019s website at https:\/\/www.revbiosciences.com<\/a>. A replay of the presentation will be available on Revelation\u2019s website for 30 days following the event.\n<\/p>\n

\nMr. Rolke will be available for one-on-one meetings throughout the conference in person and virtually.\n<\/p>\n

\nAbout Revelation Biosciences Inc.<\/b>\n<\/p>\n

\nRevelation Biosciences, Inc. is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has multiple product candidates in development that are based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system. REVTx\u2011100 is being developed as a prevention and treatment of infection. REVTx\u2011200 is being developed as an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx\u2011300 is being developed as a potential therapy for the treatment of acute and chronic organ disease including AKI, CKD, myocarditis, and NASH. REVTx\u201199b is being developed as a treatment for food allergies. REVDx\u2011501 is being developed as a rapid diagnostic that can be used to detect IP-10 as a surrogate biomarker for any type of respiratory infection, eliminating the need for specialized instrumentation.\n<\/p>\n

\nFor more information on Revelation, please visit www.RevBiosciences.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSandra Vedrick
\n
Vice President, Investor Relations & Human Resources<\/i>
Revelation Biosciences Inc.
\n
Email: svedrick@revbiosciences.com<\/a>\n<\/p>\n

\nand<\/i>\n<\/p>\n

\nChester Zygmont, III
\n
Chief Financial Officer<\/i>
Revelation Biosciences Inc.
\n
Email: czygmont@revbiosciences.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–#biotechnews–Revelation Biosciences Inc. (NASDAQ: REVB) (the \u201cCompany\u201d or \u201cRevelation\u201d), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54520","6":"format-standard","7":"category-industry"},"yoast_head":"\nRevelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–#biotechnews–Revelation Biosciences Inc. (NASDAQ: REVB) (the \u201cCompany\u201d or \u201cRevelation\u201d), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-06T14:04:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference\",\"datePublished\":\"2023-03-06T14:04:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/\"},\"wordCount\":370,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005202\\\/en\\\/839057\\\/21\\\/revelation.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/\",\"name\":\"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005202\\\/en\\\/839057\\\/21\\\/revelation.jpg\",\"datePublished\":\"2023-03-06T14:04:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005202\\\/en\\\/839057\\\/21\\\/revelation.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230306005202\\\/en\\\/839057\\\/21\\\/revelation.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–#biotechnews–Revelation Biosciences Inc. (NASDAQ: REVB) (the \u201cCompany\u201d or \u201cRevelation\u201d), a life sciences company that is focused on the development of immunologic-based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a fireside chat at the 35th Annual Roth Conference scheduled for March ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-06T14:04:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference","datePublished":"2023-03-06T14:04:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/"},"wordCount":370,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/","url":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/","name":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg","datePublished":"2023-03-06T14:04:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230306005202\/en\/839057\/21\/revelation.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/revelation-biosciences-inc-to-participate-in-a-fireside-chat-at-the-35th-annual-roth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54520"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54520\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}